MPS LimitedMPSLTDNSE
Acquisition announced
As filed · Updates
M&AWatchMajormateriality 79 out of 100
What happened
Fact18 February 2026 at 07:00 P.M. (IST), on the acquisition of Unbound Medicine, Inc., USA by MPS.
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedEarlierFY24
We remain committed to our updated acquisition strategy and will continue to prudently allocate capital that should further our growth agenda in FY25 beyond what we see today.
NowFY24
In FY24, we officially launched THINK365, a concept for DigiCorePro, and acquired the Curie platform.
Change
FactTimeline delay
Implication
CapitSignal interpretationThe earlier statement indicates a commitment to capital allocation for FY25, while the current statement focuses on actions taken in FY24, suggesting a shift in focus to a later timeline for growth initiatives.
Watch next
Fact- Consideration and how it is funded
- Revenue and profit of the target
- Expected completion date
- ~21% three-year EBITDA CAGR (FY24 to FY27), built bottom-up from each segment operating plan (management committed by FY27)
- FY27: TRACKING TO COMFORTABLY CROSS INR 300 CRORES IN EBITDA (management committed by FY27)
Evidence
- MPS Limited has informed the Exchange regarding 'Transcript of the Conference Call on the Acquisition of Unbound Medicine, Inc., USA'.(opens the original filing in a new tab)
- Earlier statement · FY24
- Latest statement · FY24
- Earlier statement · FY24
How CapitSignal classified this
- Reasoning:
- ACQUISITION base 74; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%